Pi Financial set a C$7.00 target price on OrganiGram (CVE:OGI) in a research report sent to investors on Tuesday morning, BayStreet.CA reports. The brokerage currently has a buy rating on the stock.
A number of other research analysts have also recently commented on the company. Jefferies Financial Group raised OrganiGram from a hold rating to a buy rating and cut their target price for the company from C$10.50 to C$8.20 in a research note on Friday, October 11th. Raymond James set a C$9.00 target price on OrganiGram and gave the company an outperform rating in a research note on Tuesday. AltaCorp Capital cut their target price on OrganiGram from C$13.15 to C$6.50 in a research note on Tuesday, November 12th. Canaccord Genuity cut their target price on OrganiGram from C$8.50 to C$7.00 in a research note on Wednesday, November 13th. Finally, CIBC set a C$9.00 price objective on OrganiGram and gave the stock an outperform rating in a research note on Tuesday, September 24th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of C$7.34.
The company has a market capitalization of $661.23 million and a PE ratio of 28.02. The company’s 50 day simple moving average is C$6.22 and its 200 day simple moving average is C$7.97. OrganiGram has a 52 week low of C$4.11 and a 52 week high of C$11.30. The company has a debt-to-equity ratio of 14.71, a quick ratio of 4.14 and a current ratio of 9.06.
OrganiGram Holdings Inc, through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders.
Read More: What is the price-sales ratio?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.